Researchclopedia
Research
Researchers
Institutions
Topics
Submit
About
Search...
⌘
K
Command Palette
Search for a command to run...
Back to research
Dual EGFR-VEGF Pathway Inhibition: A Promising Strategy for Patients With EGFR-Mutant NSCLC
2020
320 citations
Review
Field-Weighted Citation Impact:
18.99
Dual EGFR-VEGF Pathway Inhibition: A Promising Strategy for Patients With EGFR-Mutant NSCLC | Researchclopedia
·
Hospital Universitario 12 De Octubre
Bente Frimodt‐Moller
Katharina Wolff
·
Hesse (Germany)
Carla Visseren‐Grul
·
Eli Lilly (Netherlands)
John V. Heymach
·
The University of Texas MD Anderson Cancer Center
Edward B. Garon
·
University of California, Los Angeles